SCHEMBL486311

SCHEMBL486311

O=C(O)Oc1cncc(Cl)c1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686904 0.85 KMT2A (0.40) MAPTKMT2A
SCHEMBL28723828 0.82 MAPT (0.54) MAPTKMT2A
SCHEMBL27832542 0.78 MAPT (0.50) MAPTKMT2A
SCHEMBL674112 0.76 MEN1 (0.52) KMT2A
SCHEMBL9649335 0.76 HCAR2 (0.52)
SCHEMBL5674900 0.76 POLB (0.52)
SCHEMBL2841832 0.76 CHRNB2 (0.50)
SCHEMBL17993295 0.74 MAPT (0.46) MAPTKMT2A
SCHEMBL28347900 0.73 SIRT2 (0.53) KMT2A
SCHEMBL27610932 0.72 CHRNB2 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411363-B1 SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS BAYER IP GMBH (DE) 2015-10-07 EP disclosed
EP-2411363-A1 SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS Bayer Pharma AG (DE) 2012-02-01 EP disclosed
WO-2010108608-A1 SUBSTITUTED PIPERIDINES AS PAR-1 ANTAGONISTS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-30 WO disclosed